Fontolizumab Protein Design Labs.

Article Details

Citation
Copy to clipboard

Dumont FJ

Fontolizumab Protein Design Labs.

Curr Opin Investig Drugs. 2005 May;6(5):537-44.

PubMed ID
15912969 [ View in PubMed
]
Abstract

Protein Design Labs is developing fontolizumab, a humanized anti-interferon gamma monoclonal antibody, for the potential treatment of autoimmune diseases. By February 2003, the company was actively seeking to outlicense the development and commercialization rights to fontolizumab outside of the US and Canada.

DrugBank Data that Cites this Article

Drugs